UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000011793 |
|---|---|
| Receipt number | R000013790 |
| Scientific Title | The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes. |
| Date of disclosure of the study information | 2013/09/18 |
| Last modified on | 2014/09/03 12:16:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes.
Acronym
The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes.
Scientific Title
The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes.
Scientific Title:Acronym
The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes.
Region
| Japan |
Condition
Condition
Type 2 diabetes
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To access the effect of coadministration of oral hypoglycemic agents and long acting insulin.
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The ahievemnt rate of taeget glucose value
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Drug administration(Insulin glargine, metoformin, miglitol, and mitiglinide)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 79 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Inpatients of 30-79 year old type 2 diabetes whose HbA1c levels are more than 7.0% with the teratment of oral hypoglyceamic agents and insulin.
Key exclusion criteria
Patients with severe liver dysfunction and renal dysfunction or type 1 diabetes.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Mitsuhiko Noda |
Organization
National Center for Global Health and Medicine
Division name
Depertment of Diabetes Research
Zip code
Address
1-21-1Toyama, Shinjukuku, Tokyo, Japan
TEL
03-3202-7181
mnoda@hosp.ncgm.go.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Noriko Ihana |
Organization
National Center for Global Health and Medicine
Division name
Depertment of Diabetes, Metabolism, and Endocrinology
Zip code
Address
1-21-1Toyama, Shinjukuku, Tokyo, Japan
TEL
03-3202-7181
Homepage URL
nori_3373@yahoo.co.jp
Sponsor or person
Institute
National Center for Global Health and Medicine
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 09 | Month | 18 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2011 | Year | 06 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2011 | Year | 08 | Month | 05 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 09 | Month | 18 | Day |
Last modified on
| 2014 | Year | 09 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013790
